Preclinical Drug Development Solutions

Pharmacodynamic Evaluation

Large Animal Models

Myocardial infarction (pig), diabetes (NHP), stroke (dog), and other clinically relevant disease models.

Small Animal Models

Xenograft tumour models, Alzheimer’s disease (transgenic mice), and inflammation models.

Pharmacokinetics & Toxicology (DMPK)

In Vitro Studies

Caco-2 permeability, CYP induction/inhibition, and metabolite profiling.

In Vivo ADME

PK/PD studies in rodents, rabbits, and non-human primates.

Toxicokinetics

Dose range finding and safety margin evaluation.

GLP Safety Assessment

Acute and chronic toxicity

Genotoxicity and carcinogenicity

Cardiovascular (hERG) and respiratory safety

Biomarker-based risk assessment

SPF & Conventional Animal Housing

Imaging & Surgery Suites

Molecular & Pathology Labs

Why Partner with HuaTeng Biotechnology?

Full-Service Expertise: Efficacy, pharmacokinetics (PK/PD), and safety studies under one roof

Globally Accredited Labs: GLP-compliant facilities aligned with OECD, FDA, and NMPA standards

Advanced Infrastructure: SPF-grade animal housing, laminar flow labs, CT/micro-CT imaging, and automated analytics

Species Diversity: Large (NHP, dogs, minipigs) and small (mice, rats) animal models for human-relevant insights

Data-Driven Outcomes: AI-powered analytics and customizable reporting for confident decision-making

Ready to Accelerate Your Program?

Contact us today to discuss your preclinical needs. Our team delivers tailored solutions, transparent timelines, and competitive pricing to keep your pipeline moving forward.

Drug Efficacy Testing in Preclinical Studies

HuaTeng Biotechnology provides comprehensive preclinical efficacy studies to evaluate therapeutic potential, optimize drug candidates, and generate robust data packages for IND submissions. Our customized models bridge the gap between in vitro findings and clinical outcomes.

Learn More

ADME/PK Profiling Services

At HuaTeng Biotechnology, we deliver end-to-end ADME/PK profiling services to optimize drug discovery and development, ensuring robust pharmacokinetic and safety data for small molecules, biologics, and novel modalities. Our globally compliant studies bridge preclinical and clinical phases, empowering you to prioritize candidates, mitigate attrition risks, and meet regulatory milestones.

Learn More

GLP Toxicology & Safety Pharmacology

HuaTeng Biotechnology provides end-to-end GLP-certified safety & toxicology studies for global clients. Expertise in small (rodent) and large animal models (NHP/canine). OECD, FDA, ICH compliant. Fast-track your drug development.

Learn More

Why Choose HuaTeng Biotechnology for GLP-Compliant Testing?

Trusted Quality. Global Compliance. Proven Execution.

Global Compliance: AAALAC-accredited facilities with IACUC oversight, aligned with EU Directive 2010/63/EU and USDA standards—ensuring full regulatory acceptance across major markets.

Advanced Imaging Capabilities: Integrated platforms including DSA, IVUS, angiography and micro-CT, enabling real-time evaluation of device performance and in vivo outcomes.

Custom Model Development: Species-specific animal models tailored to complex disease conditions, improving translational relevance and clinical predictability.

Integrated Histopathology Suite: SEM and TEM analysis supported by GLP-grade reporting, enabling seamless submission to PMDA, CE Mark and global regulatory authorities.

Preclinical Drug Development Solutions